Showing papers in "The Journal of Sexual Medicine in 2016"
••
TL;DR: The new set of definitions of all forms of sexual dysfunction in women and men adopted by the Fourth International Consultation on Sexual Medicine (ICSM) held in 2015 are presented.
358 citations
••
TL;DR: Research strongly supports the routine clinical investigation of psychological factors, partner-related factors, context, and life stressors and a biopsychosocial model to understand how these factors predispose to sexual dysfunction is recommended.
311 citations
••
TL;DR: These data need to be treated with caution, because there is a high level of variability across studies caused by methodologic differences in the instruments used to assess presence of sexual dysfunction, ages of sample, nature of samples, methodology used to gather the data, and cultural differences.
305 citations
••
TL;DR: In this large study of U.S. adults' ratings of the importance of sexual health and satisfaction with sex life, sexual health was a highly important aspect of quality of life for many participants, including participants in poor health.
294 citations
••
TL;DR: The evidence that erectile dysfunction is a harbinger of other forms of cardiovascular disease is strong enough to recommend that clinical evaluation for occult cardiovascular disease should be undertaken in men who do not have known cardiovascular disease but who develop organic erectiles dysfunction, especially in men younger than 70 years.
227 citations
••
TL;DR: Penile prosthesis remains as an important, viable, and effective treatment for male erectile dysfunction that does not respond to other less invasive approaches or when these approaches are contraindicated or not acceptable to the patient.
212 citations
••
TL;DR: The empirical literature on the prevalence of transgender highlights the importance of adhering to specific case definitions because the results can range by orders of magnitude.
212 citations
••
TL;DR: Longitudinal research is needed to shed light on risk factors involved in the expression of vulvodynia, as well as in potential subgroups of affected patients, in order to develop an empirically supported treatment algorithm.
207 citations
••
TL;DR: A comprehensive assessment is needed to understand the pain experience of women presenting with vulvodynia, and several treatment options are worth pursuing.
198 citations
••
TL;DR: A greater understanding of the scientific basis of PD is greatly needed to address theUnderstanding of the pathophysiology, clinical epidemiology, psychosocial, and diagnostic assessment as well as treatment strategies are greatly needed.
155 citations
••
TL;DR: In 2015, the ISSVD, ISSWSH, and IPPS adopted a new vulvar pain and vulvodynia terminology that acknowledges the complexity of the clinical presentation and pathophysiology involved in vulvar relief and incorporates new information derived from evidence-based studies conducted since the last terminology published in 2003.
••
TL;DR: PDE5 inhibitors remain a first-line treatment option because of their excellent efficacy and safety profile and intraurethral and topical alprostadil provide an alternative, less invasive treatment option.
••
TL;DR: Level of evidence (LoEs) and grades of recommendations are provided based on a thorough analysis of the literature and committee consensus on the diagnosis and management of Testosterone deficiency.
••
TL;DR: It is found that SPPA is most frequently operationalized as excessive pornography use and negative consequences, and some methodologic limitations of the primary studies, which limit the strength of the conclusions that can be drawn.
••
TL;DR: Testosterone has a primary role in controlling and synchronizing male sexual desire and arousal, acting at multiple levels, and meta-analysis indicates that testosterone therapy for hypogonadal individuals can improve low desire and erectile dysfunction.
••
TL;DR: Negative symptoms associated with PU more strongly predict seeking treatment than mere quantity of pornography consumption, and treatment of problematic PU should address qualitative factors, rather than merely mitigating the frequency of the behavior.
••
TL;DR: Differences between GB and heterosexual men in the impact of PCa on HRQOL across a range of domains are confirmed, suggesting there is a need for GB targeted PCa information and support, to address the concerns of this "hidden population" in PCa care.
••
TL;DR: LESW treatment improves erectile function in a rat model of pelvic neurovascular injury by leading to angiogenesis, tissue restoration, and nerve generation with more endogenous EdU(+) progenitor cells recruited to the damaged area and activation of Schwann cells.
••
TL;DR: Defined principles, an algorithm and a range of scales may provide coherent and evidence based management for sexual dysfunctions.
••
TL;DR: The central considerations and issues that underlie the development of a new evidence-based nomenclature that reliably and validly defines the categories of FSD and will effectively function in clinical and research settings, serve as a basis for International Classification of Diseases codes, and provide regulatory guidance for interventions designed as FSD treatments are reviewed.
••
TL;DR: Mastectomy improved body satisfaction most strongly, although respondents reported improvements in all domains (eg, decreased dysphoria when looking in the mirror and improved feelings of self-worth).
••
TL;DR: It is recommended that clinicians evaluate their patients and their partners in the context of culture and assess distressing sexual symptoms regardless of whether they are a recognized dysfunction, and researchers should develop culturally sensitive assessment skills and instruments.
••
TL;DR: Routine monitoring of gonadotropin-releasing hormone agonists, sex steroids, creatinine, and liver function is not necessary during treatment with triptorelin, and data suggest Triptorelin effectively suppresses puberty in gender dysphoric adolescents.
••
TL;DR: Available data support an important role of androgens in female sexual function and dysfunction and efficacy of transdermal T therapy for the treatment of some women with FSD.
••
TL;DR: A detailed description of the study protocol, objectives, and design of the ENIGI Endocrine protocol is given, which aims to evaluate clinical and side-effects of cross-sex hormonal treatment in trans persons.
••
TL;DR: Findings confirm that NSSI is common in trans youth and emphasize the need for interventions that decrease transphobia, increase social support, and help trans youth navigate their relationships with others to decrease psychopathology and NSSi.
••
TL;DR: Convective water vapor thermal therapy provides sustainable improvements for 12 months to lower urinary tract symptoms and urinary flow while preserving erectile and ejaculatory functions.
••
TL;DR: The results of the study suggest that CBT and PT can lead to clinically meaningful improvements in pain and areas of psychosexual functioning.
••
TL;DR: For sexual problems, the treatment of VVA remains the most pertinent indication for estrogen therapy, and systemic estrogen therapy with combined estrogen and progestin in non-hysterectomized women is indicated.
••
TL;DR: This group of relatively young transgender women reported satisfactory functional and esthetic results of the neovagina and a good quality of life, despite low Female Sexual Function Index scores.